ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,140, issued on Sept. 9, was assigned to Bionomics Ltd. (Eastwood, Australia).
"Therapeutic formulations and uses thereof" was invented by Dharam Paul (Eastwood, Australia), Julia Crossman (Eastwood, Australia), Elizabeth Doolin (Eastwood, Australia), Tom Reynolds (Bend, Ore.), Xiangming Wu (Bend, Ore.), Jeff Millan (Bend, Ore.), Thomas Stumpfig (Bend, Ore.) and Kristie Downing (Bend, Ore.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the Alpha7-nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture t...